Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. financial statements

Oramed Pharmaceuticals Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2M10-K
Net incomeUSD 64.05M10-K
Cash and equivalentsUSD 45.95M10-Q
Total debtUSD 825KEODHD

Oramed Pharmaceuticals Inc. financials on 6ix · Oramed Pharmaceuticals Inc. on 6ix